The most frequently reported combinations were BRCA1/BRCA2, BRCA2/TP53, BRCA1/MLH1, and APC/MLH1, reflecting the relevance of the most commonly screened genes for major hereditary cancer syndromes, as well as the presence of founder variants in certain populations. This evidence concerns the gene MLH1 and Inherited cancer-predisposing syndrome.